Suggestions
Rick Leach
Chief Strategy Officer at International Space Station U.S. National Laboratory
Professional Background
Rick Leach is an accomplished molecular biologist and pharmaceutical executive with a distinguished career spanning over several decades in genomics and biotechnology. Leach's extensive experience encompasses leadership roles across various reputable organizations in the field. Currently, he serves as the Chief Strategy Officer at the International Space Station U.S. National Laboratory, where he applies his expertise to innovative projects that bridge the boundary between space research and terrestrial applications. His unique approach leverages academic insight and strategic management to advance scientific frontiers.
Before his current role, Leach held notable positions that contributed significantly to advancements in genomic medicine. As the Executive Management Consultant at Genomics Medicine Ireland, he played a pivotal role in guiding the company toward leveraging genomic data for better healthcare solutions. Additionally, as the Chief Commercial Officer at WuXi NextCODE Genomics, Leach notably contributed to efforts that fueled the growth of precision medicine by driving commercial strategies to expand the use of genomic information.
Throughout his career, Leach's leadership has been instrumental in major achievements, particularly his past role as Vice President of Business Development at Complete Genomics Inc. Here, he helped steer the company's business strategies leading to enhanced collaborations and partnerships, which further established Complete Genomics as a leading player in whole genome sequencing.
Rick Leach has also held significant leadership roles at deCODE genetics, a pioneering biotechnology company known for its genomic research that helped illuminate the genetic underpinnings of a range of diseases. His expertise coupled with strong strategic insights has consistently supported companies in harnessing genomic data and translating it into effective healthcare solutions.
In addition to his corporate roles, Rick Leach has also been deeply involved in fostering advancements in genomics through his work as a Scientific & Business Consultant at Shady Grove Center for Preimplantation Genetics. His contributions have had a profound impact on genetic testing methodologies, particularly for infertility solutions.
Education and Achievements
Rick Leach's educational background lays a solid foundation for his career in molecular biology. He earned his Ph.D. in Molecular Biology from Ohio University, where he conducted extensive research and developed a strong foundation in genomic science. Prior to this, he completed his B.S. in Biology & Chemistry at Hillsdale College, which equipped him with a comprehensive understanding of biological sciences and chemistry's role in genomic research.
His contributions to the field of genomics are underscored by his co-authorship in the pivotal research paper titled, "Genome sequencing identifies major causes of severe intellectual disability." Published in Nature on July 17, 2014, this study is significant in establishing the importance of whole genome sequencing (WGS) as a clinical standard of care. The research highlighted the improved diagnostic yield achieved through WGS for individuals suffering from severe intellectual disabilities, surpassing the effectiveness of all other diagnostic methods combined. This paper is a testament to Leach's commitment to advancing our understanding of genetics and its implications on healthcare.
Rick Leach's work continues to influence the landscape of genomic medicine, where his insights into genomic data utilization are shaping the future of personalized healthcare strategies across the globe. His academic and professional endeavors showcase his steadfast dedication to innovation in molecular biology and commitment to improving patient outcomes through advanced genomic technologies.
Achievements
Apart from his significant academic contributions and impactful leadership roles, Rick Leach's career is characterized by various achievements that reflect his commitment to the field of genomics. His status as a visionary leader is supported by his tenure as a Board Member at Empirical BioSciences, where he contributed strategic insights in a company focused on the therapeutic applications of genomic data.
Leach's background not only highlights his executive experience but emphasizes his capability to navigate complex business environments while driving innovations in science. His role as Senior Field Applications Scientist at Affymetrix, Inc. underscores his technical expertise and ability to translate intricate scientific processes into practical applications that benefit the healthcare industry.
Each phase of Rick Leach’s career demonstrates his pervasive influence within the realms of genomic medicine and biotechnology. His ability to combine scientific knowledge with business acumen has not only advanced his individual career but has also significantly contributed to the evolution of healthcare practices through the integration of advanced genomic technologies.